|
PennyPerformers.com: "Penny Stocks that Perform" picks are: GD, MSA, UNDT, VPHM
(M2 PressWIRE Via Acquire Media NewsEdge)
RDATE:13032009
Pennyperformers.com "Penny Stocks that Perform" picks are: General
Dynamics General Dynamics Corp (NYSE: GD), Mine Safety Appliances Co.
(NYSE: MSA), Universal Detection Technology (OTCBB: UNDT), ViroPharma
Incorporated (NASDAQ: VPHM)...and Proudly Introducing Proprietary Push
Technology (PPT).
The Newest and Revolutionary Technology for Increasing Investor
Visability.
REAL Awareness for REAL Companies.
Click below for a full demonstration.
http://newmediaadvisors.info/newmedia.swf
Sign-up for our FREE Stock Alerts AND NEWSLETTER at
www.pennyperformers.com
March 11, 2009 -- General Dynamics Land Systems, a business unit of
General Dynamics (NYSE: GD), has been awarded a contract worth $33
million to purchase long-lead materials for the production of 140 M1A1
SA (Situational Awareness) tanks for the Iraq program.
The SA enhancements to the M1A1 for Iraq include a second generation
FLIR thermal site, Tank Urban Survivability (TUSK) enhancements and a
driver's vision-enhancing thermal viewer. The tanks will also be
equipped with the TIGER engine, the Pulse Jet System, and embedded
diagnostics. The TIGER engine has a monitoring system that is able to
identify and alert the crew if there are potential issues with the tank.
The 140 tanks will be manufactured in Lima, Ohio, by existing General
Dynamics employees.
General Dynamics, headquartered in Falls Church, Va., employs
approximately 92,300 people worldwide. The company is a market leader
in business aviation; land and expeditionary combat systems, armaments
and munitions; shipbuilding and marine systems; and information systems
and technologies.
March 13, 2009 -- Mine Safety Appliances Co. (MSA) (NYSE: MSA)
announced today that it has been awarded a two-year $45 million
indefinite delivery/indefinite quantity (IDIQ) contract from the
Defense Supply Center Philadelphia (DSCP) to supply U.S. military
forces with Advanced Combat Helmets. Delivery of the helmets will begin
in the third quarter of 2009, pending first article testing and
certification.
MSA began producing ballistic helmets for the U.S. military in 2002
and, in partnership with the U.S. Army, developed the concept for the
Advanced Combat Helmet (ACH). The ACH incorporates a lightweight design
that offers soldiers advanced ballistic protection with greater
comfort, stability and situational awareness. Since adoption by the
Army as the standard basis of issue, the ACH has been credited with
saving numerous lives in military actions in Iraq and Afghanistan.
"Following the completion of several long-term ACH contracts, this
award represents a new and exciting phase of ACH production at MSA,"
said Bill Lambert, MSA President and Chief Executive Officer. "We're
grateful for the trust the U.S. military has placed in MSA and for the
opportunity to continue to serve as a partner in the effort to provide
our fighting men and women in uniform with the highest level of
protection possible."
Mr. Lambert noted that the ACH award represents particularly good news
for MSA employees located at the company's manufacturing facility in
Newport, Vt. "Our associates there have done an exemplary job in
meeting the ballistic helmet needs of the U.S. Army since we began
production there in 2002. This latest award gives MSA the opportunity
to continue ACH production at Newport and leverage the broad ballistic
protection expertise our associates there have attained over the past
several years."
U.S. Senator Patrick Leahy (D-Vt.), senior member of the U.S. Senate
Defense Appropriations Subcommittee and Co-Chair of the U.S. Senate
National Guard Caucus, was equally pleased with the military's decision
to have ACH production continue in his home state. "The men and women
at MSA of Newport have delivered tens of thousands of expertly made
helmets to the U.S. Army," Senator Leahy said. "These Vermonters have
put their skill and energy and dedication into those helmets, which
have saved soldiers' lives during hard deployments in Iraq and
Afghanistan. This long-term sustainment purchase secures Newport's
place as a preferred military helmet supplier for the next two years
and, I hope, beyond. "
MSA also provides ballistic helmets to special branches of the U.S.
Department of Defense, military forces in Europe, and the Canadian
Military.
Established in 1914, MSA is a global leader in the development,
manufacture and supply of safety products that protect people's health
and safety. Many MSA products typically integrate any combination of
electronics, mechanical systems and advanced materials to protect users
against hazardous or life-threatening situations. The company's
comprehensive line of products is used by workers around the world in
the fire service, oil, gas and petrochemical industry, homeland
security, construction, mining and other industries, as well as the
military. Principal products include self-contained breathing
apparatus, gas masks, gas detection instruments, head protection,
ballistic body armor, fall protection devices and thermal imaging
cameras. The company also provides a broad range of consumer and
contractor safety products through retail channels. These products are
marketed and sold under the MSA Safety Works brand. MSA has annual
sales of approximately $1 billion, manufacturing operations in the
United States, Europe, Asia and Latin America, and more than 40
international locations.
Mar 13, 2009 -- Universal Detection Technology (OTCBB: UNDT), a
developer of early-warning monitoring technologies to protect people
from bioterrorism and other infectious health threats and provider of
counter-terrorism consulting and training services, reported today that
it has received a purchase order for its five-agent bioterrorism
detection Equipment from the Miami-Dade Police Department. The
Equipment is capable of spot detection of anthrax, ricin toxin,
botulinum toxin, plague, and SEBs. The purchase order also includes
kits that mimic a "suspicious powder" scenario thus preparing the first
responders for a real world event.
The Miami-Dade Police Department (MDPD) is the largest police
department in the Southeastern United States, with approximately 4,500
employees. The MDPD has a dedicated anti-terror unit with officers
specializing in biological and chemical warfare detection methods.
UNDT's 5-agent detection equipment has been extensively used by first
responders and private industry throughout the country. The equipment
has been evaluated by the U.S. DOD as well as the United Kingdom
military. The equipment's capacities include:
* No cross-reactivity with near neighbor strains
* No cross-reactivity to household powders
* No set up time
* No expensive reader needed
* No decontamination requirements
* No false positives
* No false negatives
* No hook effect
"This is the second order for our equipment from a major metropolitan
first responder agency in the last few months," said Mr. Jacques
Tizabi, UNDT's Chief Executive Officer. "We will continue to expand the
marketing of our detection equipment in the coming year," he added.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring
technologies, including bioterrorism detection devices. The Company on
its own and with development partners is positioned to capitalize on
opportunities related to Homeland Security. For example, the Company,
in cooperation with NASA, has developed a bacterial spore detector that
detects certain biohazard substances. The Company is also a reseller of
handheld assays used for detection of five bioterrorism agents,
radiation detection systems, and antimicrobial products.
March 11, 2009 -- ViroPharma Incorporated (NASDAQ: VPHM) today
announced that Vincent Milano, president and chief executive officer of
ViroPharma, will present at the Cowen & Company 29th Annual Healthcare
Conference at 11:00 A.M. ET on Wednesday, March 18, 2009. The
conference is being held at the Boston Marriott Copley Place.
ViroPharma's presentations will be webcast live for investors on the
company's website and available for a period of 14 days following the
conferences.
About ViroPharma Incorporated
ViroPharma Incorporated is a biopharmaceutical company dedicated to the
development and commercialization of products that address serious
diseases treated by physician specialists and in hospital settings.
ViroPharma commercializes Vancocin(R) (vancomycin hydrochloride
capsules, USP), approved for oral administration for treatment of
antibiotic-associated pseudomembranous colitis caused by Clostridium
difficile and enterocolitis caused by Staphylococcus aureus, including
methicillin-resistant strains, and Cinryze(TM) (C1 inhibitor (human))
for routine prophylaxis against angioedema attacks in adolescent and
adult patients with hereditary angioedema (HAE), also known as C1
inhibitor deficiency (for prescribing information on ViroPharma's
commercial products, please download the package inserts at. ViroPharma
currently focuses its drug development activities in diseases including
cytomegalovirus (CMV), HAE and C. difficile.
About PennyPerformers.com
PennyPerformers.com has become one of the premier stops for investors
who wish to experience huge profits via investing in up-and-coming
publicly traded companies.
Penny Performers email report service is free to those investors who
sign up on our website. The alert service is designed to notify
investors of undervalued and often overlooked stocks. Subscribers are
introduced to OTCBB and Pinksheet companies that have the potential of
showing increased activity and Standing Out from the rest of the
market. To subscribe to this free service, visit the Penny Performers
Report home page at www.PennyPerformers.com and select the "join now"
button.
Join us at www.PennyPerformers.com for a complimentary subscription to
the most exciting online financial newsletter on the market.
Disclaimer: Verify all claims and do your own due diligence.
PennyPerformers.com profiles are not a solicitation or recommendation
to buy, sell or hold securities. PennyPerformers.com is not offering
securities for sale. An offer to buy or sell can be made only with
accompanying disclosure documents and only in the states and provinces
for which they are approved. All statements and expressions are the
sole opinion of the editor and are subject to change without notice.
PennyPerformers.com is not liable for any investment decisions by its
readers or subscribers. It is strongly recommended that any purchase or
sale decision be discussed with a financial adviser, or a
broker-dealer, or a member of any financial regulatory bodies. The
information contained herein has been provided as an information
service only. The accuracy or completeness of the information is not
warranted and is only as reliable as the sources from which it was
obtained. It should be understood there is no guarantee that past
performance will be indicative of future results. Investors are
cautioned that they may lose all or a portion of their investment in
this or any other company. In order to be in full compliance with the
Securities Act of 1933, Section 17(b), PennyPerformers.com is owned and
operated by PennyPerformers.com. Neither PennyPerformers.com nor any of
its affiliates, or employees shall be liable to you or anyone else for
any loss or damages from use of this e-mail, caused in whole or part by
its negligence or contingencies beyond its control in procuring,
compiling, interpreting, reporting, or delivering this Web Site or
e-mail and any contents. Since PennyPerformers.com receives
compensation and its employees or members of their families may hold
stock in the profiled companies, there is an inherent conflict of
interest in PennyPerformers.com statements and opinions and such
statements and opinions cannot be considered independent.
PennyPerformers.com and its management may benefit from any increase in
the share prices of the profiled companies. Information contained
herein contains "forward looking statements" within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities and Exchange Act of 1934. Any statements that express or
involve discussions with respect to predictions, expectations, beliefs,
plans, projections, objectives, goals, assumptions or future events or
performance are not statements of historical facts and may be "forward
looking statements". Forward looking statements are based on
expectations, estimates and projections at the time the statements are
made that involve a number of risks and uncertainties which could cause
actual results or events to differ materially from those presently
anticipated. PennyPerformers.com services are often paid for using
free-trading shares. PennyPerformers.com may be selling shares of stock
at the same time the profile is being disseminated to potential
investors; this should be viewed as a definite conflict of interest and
as such, the reader should take this into consideration.
Visit us for a full Disclaimer at:
www.PennyPerformers.com/disclaimer.htm
CONTACT: PennyPerformers.com
e-mail: info@pennyperformers.com
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).
Copyright ? 2009 M2 Communications Ltd.
[ Back To TMCnet.com's Homepage ]
|
INDUSTRIES
Activate Email 
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO East, January 20-22, 2010. Miami, FL.
